Hiroya Taniguchi Selected Research

Hiroya Taniguchi Research Topics

Disease

63	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 10/2013
48	Neoplasms (Cancer) 10/2023 - 10/2008
21	Stomach Neoplasms (Stomach Cancer) 10/2021 - 06/2010
9	Colonic Neoplasms (Colon Cancer) 01/2023 - 10/2008
8	Neutropenia 11/2023 - 01/2017
8	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2016
5	Febrile Neutropenia 11/2023 - 01/2017
5	Microsatellite Instability 01/2023 - 01/2020
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 01/2019
4	Adenocarcinoma 10/2023 - 01/2018
4	Disease Progression 01/2023 - 08/2011
3	Diarrhea 11/2020 - 08/2015
3	Esophageal Neoplasms (Esophageal Cancer) 10/2016 - 08/2011
2	Squamous Cell Carcinoma of Head and Neck 03/2024 - 12/2011
2	Mucositis 11/2020 - 08/2015
2	Sarcopenia 10/2018 - 06/2017
2	Nausea 01/2017 - 09/2016
2	Esophageal Squamous Cell Carcinoma 10/2016 - 08/2015
2	Prostatic Neoplasms (Prostate Cancer) 02/2011 - 11/2008
1	Nasopharyngeal Carcinoma 03/2024
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Cutaneous Fistula 08/2022
1	Fistula 08/2022
1	Lymphatic Metastasis 04/2022
1	Leiomyosarcoma 12/2021

Drug/Important Bio-Agent (IBA)

21	Bevacizumab (Avastin)FDA Link 01/2024 - 02/2014
18	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 06/2010
17	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 08/2012
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2014
14	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 08/2012
12	trifluridine tipiracil drug combinationIBA 01/2024 - 01/2017
10	Cetuximab (Erbitux)FDA Link 03/2024 - 09/2015
10	Circulating Tumor DNAIBA 01/2023 - 12/2020
9	Leucovorin (Folinic Acid)FDA Link 03/2023 - 08/2012
9	regorafenibIBA 01/2021 - 01/2017
8	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 04/2009
6	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2020
6	Panitumumab (Vectibix)FDA Link 06/2021 - 03/2016
6	ErbB Receptors (EGF Receptor)IBA 06/2021 - 04/2015
4	pembrolizumabIBA 03/2024 - 01/2020
4	Trastuzumab (Herceptin)FDA Link 01/2023 - 08/2017
4	NivolumabIBA 12/2021 - 11/2018
4	human ERBB2 proteinIBA 11/2021 - 08/2017
4	RamucirumabIBA 10/2021 - 01/2019
4	AntibodiesIBA 01/2019 - 01/2017
3	Growth Factor ReceptorsIBA 01/2023 - 03/2016
3	Capecitabine (Xeloda)FDA Link 12/2021 - 01/2021
3	Taxoids (Taxanes)IBA 01/2020 - 08/2012
3	BilirubinIBA 01/2019 - 01/2016
3	S-1 plus cisplatinIBA 08/2014 - 08/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2011 - 10/2008
3	LigandsIBA 02/2011 - 10/2008
2	binimetinibIBA 03/2024 - 01/2020
2	encorafenibIBA 03/2024 - 01/2020
2	Gemcitabine FDA Link 03/2024 - 04/2009
2	Cell-Free Nucleic AcidsIBA 01/2024 - 10/2023
2	pertuzumabIBA 01/2023 - 11/2021
2	Monoclonal AntibodiesIBA 01/2023 - 06/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 01/2018
2	Cytotoxins (Cytolysins)IBA 04/2020 - 08/2017
2	Antineoplastic Agents (Antineoplastics)IBA 03/2020 - 10/2012
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2017
2	taxaneIBA 01/2019 - 09/2017
2	PlatinumIBA 11/2018 - 12/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 01/2017
2	Docetaxel (Taxotere)FDA Link 08/2015 - 04/2009
1	B7-H1 AntigenIBA 03/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 10/2023
1	Trifluridine (Viroptic)FDA LinkGeneric 01/2023
1	Notch ReceptorsIBA 10/2022
1	TAS-116IBA 12/2021
1	quinone (benzoquinone)IBA 11/2021
1	Oxidoreductases (Dehydrogenase)IBA 11/2021
1	napabucasinIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	NAD (NADH)IBA 11/2021
1	Vascular Endothelial Growth Factor DIBA 10/2021
1	Tumor Biomarkers (Tumor Markers)IBA 07/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 03/2020
1	TropomyosinIBA 03/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2020
1	Lipase (Acid Lipase)FDA Link 01/2020

Therapy/Procedure

42	Drug Therapy (Chemotherapy) 03/2024 - 04/2009
36	Therapeutics 03/2024 - 11/2008
6	Adjuvant Chemotherapy 01/2023 - 04/2015
3	Immunotherapy 09/2022 - 02/2020
3	Neoadjuvant Therapy 08/2022 - 08/2015
3	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 06/2010
3	Chemoradiotherapy 10/2016 - 08/2011
2	Hepatectomy 10/2021 - 08/2021
2	Drug Tapering 06/2017 - 08/2015
1	Ileostomy 08/2022
1	Colectomy 08/2022
1	Aftercare (After-Treatment) 04/2022
1	Lymph Node Excision (Lymph Node Dissection) 04/2022
1	Precision Medicine 11/2021
1	Radiotherapy 01/2020